M28 Capital Management as of Sept. 30, 2022
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 12 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adagio Therapeutics (IVVD) | 30.2 | $29M | 9.2M | 3.13 | |
| Wave Life Sciences SHS (WVE) | 30.1 | $29M | 8.0M | 3.61 | |
| Rocket Pharmaceuticals (RCKT) | 11.1 | $11M | 666k | 15.96 | |
| Stoke Therapeutics (STOK) | 7.0 | $6.7M | 523k | 12.84 | |
| Bridgebio Pharma (BBIO) | 5.3 | $5.1M | 513k | 9.94 | |
| Mirati Therapeutics | 4.5 | $4.3M | 61k | 69.84 | |
| Curis Com New | 3.3 | $3.1M | 4.5M | 0.70 | |
| Verve Therapeutics (VERV) | 3.1 | $3.0M | 88k | 34.35 | |
| Leap Therapeutics | 2.4 | $2.3M | 2.7M | 0.88 | |
| Tg Therapeutics (TGTX) | 2.1 | $2.0M | 339k | 5.92 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.8 | $745k | 1.0M | 0.74 | |
| Neximmune | 0.1 | $74k | 133k | 0.55 |
